Search All UT System Experts

Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma

Joseph M. Herman, Katherine Y. Fan, Aaron T. Wild, Laura D. Wood, Amanda L. Blackford, Ross C. Donehower, Manuel Hidalgo, Richard D. Schulick, Barish H. Edil, Michael A. Choti, Ralph H. Hruban, Timothy M. Pawlik, John L. Cameron, Daniel A. Laheru, Christine A. Iacobuzio-Donahue, Christopher L. Wolfgang

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma'. Together they form a unique fingerprint.